{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:12:06Z","timestamp":1763035926120},"reference-count":113,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.vaccine.2004.08.039","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T17:34:08Z","timestamp":1097602448000},"page":"1209-1224","source":"Crossref","is-referenced-by-count":55,"title":["Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines"],"prefix":"10.1016","volume":"23","author":[{"given":"Maureen","family":"Dennehy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"30","key":"10.1016\/j.vaccine.2004.08.039_bib1","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/S0264-410X(01)00155-4","article-title":"Recombinant BCG vaccines","volume":"19","author":"Ohara","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2004.08.039_bib2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0264-410X(00)00070-0","article-title":"Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: malE","volume":"18","author":"Himmelrich","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.039_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1574-6968.1985.tb01016.x","article-title":"Cloning and expression of mycobacterial plasmid DNA in Escherichia coli","volume":"30","author":"Labidi","year":"1985","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2004.08.039_bib4","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1073\/pnas.85.18.6987","article-title":"Lysogeny and transformation in mycobacteria: stable expression of foreign genes","volume":"85","author":"Snapper","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6326","key":"10.1016\/j.vaccine.2004.08.039_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.08.039_bib6","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1073\/pnas.88.8.3111","article-title":"Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin","volume":"88","author":"Lee","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6326","key":"10.1016\/j.vaccine.2004.08.039_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/351479a0","article-title":"Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines","volume":"351","author":"Aldovini","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.08.039_bib8","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1128\/IAI.58.12.4049-4054.1990","article-title":"Establishment of a foreign antigen secretion system in mycobacteria","volume":"58","author":"Matsuo","year":"1990","journal-title":"Infect Immun"},{"issue":"22","key":"10.1016\/j.vaccine.2004.08.039_bib9","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1111\/j.1365-2958.1992.tb02201.x","article-title":"Expression of Escherichia coli (beta)-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses","volume":"6","author":"Murray","year":"1992","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.vaccine.2004.08.039_bib11","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1128\/jb.176.21.6749-6753.1994","article-title":"Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series","volume":"176","author":"Timm","year":"1994","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-1119(91)90587-2","article-title":"Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein","volume":"109","author":"Winter","year":"1991","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.vaccine.2004.08.039_bib13","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1073\/pnas.75.10.4801","article-title":"Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli","volume":"75","author":"Brosius","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2004.08.039_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0962-8479(97)90001-0","article-title":"Mycobacterial promoters","volume":"78","author":"Mulder","year":"1997","journal-title":"Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1006\/bbrc.1998.8724","article-title":"Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines","volume":"246","author":"Das Gupta","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2004.08.039_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1574-6968.2000.tb09304.x","article-title":"Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis","volume":"190","author":"Dhar","year":"2000","journal-title":"FEMS Microbiol Lett"},{"issue":"8","key":"10.1016\/j.vaccine.2004.08.039_bib17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1099\/13500872-141-8-1785","article-title":"Activity of mycobacterial promoters during intracellular and extracellular growth","volume":"141","author":"Dellagostin","year":"1995","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2958.1993.tb00970.x","article-title":"Construction and use of integrative vectors to express foreign genes in mycobacteria","volume":"10","author":"Dellagostin","year":"1993","journal-title":"Mol Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2004.08.039_bib19","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1128\/jb.178.11.3314-3321.1996","article-title":"Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA","volume":"178","author":"Via","year":"1996","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1574-6968.1998.tb13307.x","article-title":"Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium","volume":"169","author":"Batoni","year":"1998","journal-title":"FEMS Microbiol Lett"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2958.1995.mmi_17050901.x","article-title":"Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages","volume":"17","author":"Dhandayuthapani","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2004.08.039_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0264-410X(01)00414-5","article-title":"Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice","volume":"20","author":"Da Cruz","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0166-6851(93)90249-W","article-title":"Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria","volume":"57","author":"Haeseleer","year":"1993","journal-title":"Mol Biochem Parasitol"},{"issue":"13","key":"10.1016\/j.vaccine.2004.08.039_bib24","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1128\/JB.182.13.3832-3838.2000","article-title":"An essential two-component signal transduction system in mycobacterium tuberculosis","volume":"182","author":"Zahrt","year":"2000","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1128\/IAI.61.4.1509-1515.1993","article-title":"Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19-kilodalton antigens in other mycobacteria","volume":"61","author":"Booth","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.08.039_bib26","series-title":"Tuberculosis: pathogenesis, protection, and control","first-page":"239","article-title":"Expression of foreign genes in mycobacteria","author":"Burlein","year":"1994"},{"issue":"24","key":"10.1016\/j.vaccine.2004.08.039_bib27","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63","volume":"90","author":"Connell","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2004.08.039_bib28","first-page":"797","article-title":"Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B\u2032 strains by recombinant Mycobacterium bovis BCG-based candidate vaccine","volume":"20","author":"Chujoh","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.039_bib29","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","article-title":"Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A","volume":"180","author":"Langermann","year":"1994","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.70.1.303-314.2002","article-title":"Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses","volume":"70","author":"Mederle","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2004.08.039_bib31","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/IAI.67.10.5100-5105.1999","article-title":"Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein","volume":"67","author":"Abomoelak","year":"1999","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.039_bib32","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/13500872-141-7-1585","article-title":"Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB\/c mice","volume":"141","author":"Abdelhak","year":"1995","journal-title":"Microbiology"},{"issue":"8","key":"10.1016\/j.vaccine.2004.08.039_bib33","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/IAI.65.8.3057-3064.1997","article-title":"Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen","volume":"65","author":"Lagranderie","year":"1997","journal-title":"Infect Immun"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2004.08.039_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-2478(98)00128-X","article-title":"Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development","volume":"65","author":"Kaufmann","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2004.08.039_bib35","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.1073\/pnas.92.23.10693","article-title":"Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals","volume":"92","author":"Honda","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2004.08.039_bib36","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.194.10.1421","article-title":"Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation","volume":"194","author":"Ramachandra","year":"2001","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4049\/jimmunol.166.1.447","article-title":"Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria","volume":"166","author":"Neyrolles","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/MMBR.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2004.08.039_bib39","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/IAI.64.8.3038-3047.1996","article-title":"Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis","volume":"64","author":"Harth","year":"1996","journal-title":"Infect Immun"},{"issue":"25","key":"10.1016\/j.vaccine.2004.08.039_bib40","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2958.2001.02280.x","article-title":"An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes","volume":"39","author":"Wilkinson","year":"2001","journal-title":"Mol Microbiol"},{"issue":"5317","key":"10.1016\/j.vaccine.2004.08.039_bib42","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"Belisle","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2004.08.039_bib43","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1128\/jb.170.9.3847-3854.1988","article-title":"Cloning and expression of the Mycobacterium bovis BCG gene for extracellular (alpha) antigan","volume":"170","author":"Matsuo","year":"1988","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.039_bib44","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/IAI.65.6.2321-2328.1997","article-title":"High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets","volume":"65","author":"Harth","year":"1997","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/MMBR.64.3.515-547.2000","article-title":"Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome","volume":"64","author":"Tjalsma","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-6445(01)00062-6","article-title":"Translocation of proteins across the cell envelope of Gram-positive bacteria","volume":"25","author":"van Wely","year":"2001","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/jmbi.2001.4461","article-title":"An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30kDa major secretory protein (Antigen 85B), a mycolyl transferase","volume":"307","author":"Anderson","year":"2001","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib48","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.08.039_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1574-695X.2000.tb01441.x","article-title":"Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG","volume":"27","author":"Hess","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib50","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/IAI.61.4.1173-1179.1993","article-title":"Cloning and sequencing of the gene for (alpha) antigen from Mycobacterium avium and mapping of B-cell epitopes","volume":"61","author":"Ohara","year":"1993","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib51","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/IAI.67.5.2665-2670.1999","article-title":"T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs","volume":"67","author":"Lee","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib52","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/nar\/17.3.1249","article-title":"Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis","volume":"17","author":"Ashbridge","year":"1989","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/IAI.61.1.260-267.1993","article-title":"Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation","volume":"61","author":"Garbe","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.08.039_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0923-2508(91)90097-T","article-title":"Lipoprotein antigens of Mycobacterium tuberculosis","volume":"142","author":"Young","year":"1991","journal-title":"Res Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.039_bib55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(02)00318-3","article-title":"Lipopeptide vaccines\u2014yesterday, today, and tomorrow","volume":"2","author":"BenMohamed","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib56","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/eji.1830270528","article-title":"Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees","volume":"27","author":"BenMohamed","year":"1997","journal-title":"Eur J Immunol"},{"issue":"5428","key":"10.1016\/j.vaccine.2004.08.039_bib57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib58","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.4049\/jimmunol.161.5.2400","article-title":"CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein","volume":"161","author":"Mohagheghpour","year":"1998","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2004.08.039_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0161-5890(00)00066-3","article-title":"Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis","volume":"37","author":"Fonseca","year":"2000","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib60","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/IAI.65.5.1856-1862.1997","article-title":"Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae","volume":"65","author":"Abou-Zeid","year":"1997","journal-title":"Infect Immun"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2004.08.039_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(02)00443-7","article-title":"Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus","volume":"21","author":"Bastos","year":"2002","journal-title":"Vaccine"},{"issue":"9\/10","key":"10.1016\/j.vaccine.2004.08.039_bib62","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0264-410X(98)00350-8","article-title":"Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin","volume":"17","author":"Hayward","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib63","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4049\/jimmunol.168.4.1869","article-title":"Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guerin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy","volume":"168","author":"Grode","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib64","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/IAI.63.3.799-803.1995","article-title":"Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG","volume":"63","author":"Kong","year":"1995","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.039_bib65","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/514140","article-title":"Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia","volume":"176","author":"Zhu","year":"1997","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2004.08.039_bib66","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2004.08.039_bib67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0264-410X(02)00465-6","article-title":"Combined intrarectal\/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen","volume":"21","author":"Kawahara","year":"2002","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2004.08.039_bib68","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1089\/aid.1997.13.1573","article-title":"Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs","volume":"13","author":"Lim","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.039_bib69","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1099\/00221287-148-7-1999","article-title":"Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics","volume":"148","author":"Medeiros","year":"1997","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/plas.1998.1384","article-title":"Transposition-induced structural instability of Escherichia coli-mycobacteria shuttle vectors","volume":"41","author":"Chawla","year":"1999","journal-title":"Plasmid"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.039_bib71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/tube.2002.0374","article-title":"Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains","volume":"82","author":"Al-Zarouni","year":"2002","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2004.08.039_bib72","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1111\/j.1365-2958.1992.tb02201.x","article-title":"Expression of Escherichia coli \u03b2-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses","volume":"6","author":"Murray","year":"1992","journal-title":"Mol Microbiol"},{"issue":"13","key":"10.1016\/j.vaccine.2004.08.039_bib73","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0264-410X(93)90096-G","article-title":"Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen","volume":"11","author":"Lagranderie","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib74","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/172.3.698","article-title":"Recombinant bacille Calmette-Guerin priming against measles","volume":"172","author":"Fennelly","year":"1995","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2004.08.039_bib75","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2337\/diabetes.49.9.1459","article-title":"Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guerin in susceptible mice","volume":"49","author":"Choi","year":"2000","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.vaccine.2004.08.039_bib76","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/S0264-410X(99)00550-2","article-title":"Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins","volume":"18","author":"Jabbar","year":"2000","journal-title":"Vaccine"},{"issue":"7\/8","key":"10.1016\/j.vaccine.2004.08.039_bib77","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0264-410X(98)00276-X","article-title":"Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine","volume":"17","author":"Edelman","year":"1999","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2004.08.039_bib78","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/expr.1999.4459","article-title":"BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice","volume":"94","author":"Streit","year":"2000","journal-title":"Exp Parasitol"},{"issue":"11\/12","key":"10.1016\/j.vaccine.2004.08.039_bib80","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0264-410X(98)80121-7","article-title":"Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development","volume":"16","author":"Kumar","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2004.08.039_bib81","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1438-4221(01)80004-7","article-title":"Instability and site-specific excision of integration-proficient mycobacteriophage L5 plasmids: development of stably maintained integrative vectors","volume":"290","author":"Springer","year":"2001","journal-title":"Int J Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2004.08.039_bib82","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.4049\/jimmunol.156.11.4309","article-title":"Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase","volume":"156","author":"Kremer","year":"1996","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.039_bib83","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.188.5.845","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies","volume":"188","author":"Matsumoto","year":"1998","journal-title":"J Exp Med"},{"issue":"7\/8","key":"10.1016\/j.vaccine.2004.08.039_bib84","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0264-410X(98)00255-2","article-title":"Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii","volume":"17","author":"Supply","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib85","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/IAI.69.2.869-874.2001","article-title":"Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin","volume":"69","author":"Miyaji","year":"2001","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2004.08.039_bib86","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1128\/IAI.66.12.5669-5676.1998","article-title":"Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from Schistosoma haematobium","volume":"66","author":"Kremer","year":"1998","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.039_bib87","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/IAI.62.6.2508-2514.1994","article-title":"Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes","volume":"62","author":"O\u2019Donnell","year":"1994","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib88","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","article-title":"Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines","volume":"93","author":"Murray","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib89","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2567.1999.00702.x","article-title":"An in vivo comparison of bacillus Calmette-Guerin (BCG) and cytokine-secreting BCG vaccines","volume":"96","author":"Slobbe","year":"1999","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib90","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(05)67417-4","article-title":"Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2","volume":"164","author":"Yamada","year":"2000","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.2001.01428.x","article-title":"Recombinant bacille Calmette-Guerin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity","volume":"123","author":"Luo","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2004.08.039_bib92","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1128\/IAI.70.12.6549-6557.2002","article-title":"Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice","volume":"70","author":"Biet","year":"2002","journal-title":"Infect Immun"},{"issue":"6506","key":"10.1016\/j.vaccine.2004.08.039_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/372552a0","article-title":"Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi","volume":"372","author":"Langermann","year":"1994","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vaccine.2004.08.039_bib94","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1054\/tuld.1998.0202","article-title":"Vaccine protocols to optimise the protective efficacy of BCG","volume":"79","author":"Griffin","year":"1999","journal-title":"Tuberc Lung Dis"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2004.08.039_bib96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0192-0561(94)90033-7","article-title":"BCG-induced mucosal immune responses","volume":"16","author":"Gheorghiu","year":"1994","journal-title":"Int J Immunopharmacol"},{"issue":"18","key":"10.1016\/j.vaccine.2004.08.039_bib97","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1089\/aid.1998.14.1625","article-title":"A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes","volume":"14","author":"Lagranderie","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.039_bib98","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/JVI.71.3.2303-2309.1997","article-title":"Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice","volume":"71","author":"Lagranderie","year":"1997","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.039_bib99","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0897.1999.tb00439.x","article-title":"Oral vaccination of white-tailed deer using a recombinant Bacillus Calmette-Guerin vaccine expressing the Borrelia burgdorferi outer surface protein A: prospects for immunocontraception","volume":"41","author":"Miller","year":"1999","journal-title":"Am J Reprod Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2004.08.039_bib100","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0264-410X(99)00386-2","article-title":"Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice","volume":"18","author":"Lagranderie","year":"2000","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2004.08.039_bib101","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1089\/aid.1992.8.1451","article-title":"Development and analysis of recombinant BCG vector systems","volume":"8","author":"Fuerst","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"10.1016\/j.vaccine.2004.08.039_bib102","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.4049\/jimmunol.167.10.5862","article-title":"HIV mucosal vaccine: nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions","volume":"167","author":"Hiroi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.08.039_bib103","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.1999.0206","article-title":"Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree","volume":"79","author":"Oettinger","year":"1999","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2004.08.039_bib104","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(98)00277-1","article-title":"A historical and molecular phylogeny of BCG strains","volume":"17","author":"Behr","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.039_bib105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1995.tb44453.x","article-title":"Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery","volume":"754","author":"Hanson","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.039_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.08.039_bib107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG-different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2004.08.039_bib108","first-page":"191","article-title":"The effects of dispersed or surface grown cultures, manufacture and control methods on BCG standardization","volume":"58 (A)","author":"Gheorghiu","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2004.08.039_bib109","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2567.2001.01207.x","article-title":"Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model","volume":"102","author":"Janssen","year":"2001","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"issue":"7\/8","key":"10.1016\/j.vaccine.2004.08.039_bib111","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0264-410X(01)00436-4","article-title":"Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis","volume":"20","author":"Buddle","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2004.08.039_bib112","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1128\/IAI.62.10.4287-4295.1994","article-title":"Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen","volume":"62","author":"Gheorghiu","year":"1994","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.039_bib113","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0264-410X(94)90054-X","article-title":"Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop","volume":"12","author":"Kameoka","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:52:28Z","timestamp":1682779948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04006632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0264410X04006632"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.08.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}